149 related articles for article (PubMed ID: 25605162)
1. Oral and IV dosages of doxorubicin-methotrexate loaded- nanoparticles inhibit progression of oral cancer by down- regulation of matrix Methaloproteinase 2 expression in vivo.
Abbasi MM; Jahanban-Esfahlan R; Monfaredan A; Seidi K; Hamishehkar H; Khiavi MM
Asian Pac J Cancer Prev; 2014; 15(24):10705-11. PubMed ID: 25605162
[TBL] [Abstract][Full Text] [Related]
2. Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities.
Abbasi MM; Monfaredan A; Hamishehkar H; Seidi K; Jahanban- Esfahlan R
Asian Pac J Cancer Prev; 2014; 15(15):6227-32. PubMed ID: 25124602
[TBL] [Abstract][Full Text] [Related]
3. DOX-MTX-NPs augment p53 mRNA expression in OSCC model in rat: effects of IV and oral routes.
Abbasi MM; Khiavi MM; Monfaredan A; Hamishehkar H; Seidi K; Jahanban-Esfahlan R
Asian Pac J Cancer Prev; 2014; 15(19):8377-82. PubMed ID: 25339032
[TBL] [Abstract][Full Text] [Related]
4. New formulated "DOX-MTX-loaded nanoparticles" down- regulate HER2 gene expression and improve the clinical outcome in OSCCs model in rat: the effect of IV and oral modalities.
Abbasi MM; Monfaredan A; Hamishehkar H; Jahanban-Esfahlan R
Asian Pac J Cancer Prev; 2014; 15(21):9355-60. PubMed ID: 25422224
[TBL] [Abstract][Full Text] [Related]
5. Comparison of injectable doxorubicin & its nanodrug complex chemotherapy for the treatment of 4-nitroquinoline-1-oxide induced oral squamous cell carcinoma in rats.
Khiavi MM; Abdal K; Abbasi MM; Hamishehkar H; Aghbali AA; Salehi R; Sina M; Abdollahi B; Fotohi S
Indian J Med Res; 2017 Jan; 145(1):112-117. PubMed ID: 28574023
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Blood Parameters, Cardiac and Liver Enzymes in Oral Squamous Cell Carcinoma Following Treated with Injectable Doxorubicin-Loaded Nano-Particles.
Moradzadeh Khiavi M; Anvari E; Hamishehkar H; Abdal K
Asian Pac J Cancer Prev; 2019 Jul; 20(7):1973-1977. PubMed ID: 31350953
[TBL] [Abstract][Full Text] [Related]
7. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma--in vitro and in vivo studies.
Shen LC; Chen YK; Lin LM; Shaw SY
Oral Oncol; 2010 Mar; 46(3):178-84. PubMed ID: 20036604
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin combined with low intensity ultrasound suppresses the growth of oral squamous cell carcinoma in culture and in xenografts.
Fan H; Li H; Liu G; Cong W; Zhao H; Cao W; Zheng J
J Exp Clin Cancer Res; 2017 Nov; 36(1):163. PubMed ID: 29157266
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.
Pramanik KK; Nagini S; Singh AK; Mishra P; Kashyap T; Nath N; Alam M; Rana A; Mishra R
Cell Oncol (Dordr); 2018 Feb; 41(1):47-60. PubMed ID: 29134466
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer.
Jordan RC; Macabeo-Ong M; Shiboski CH; Dekker N; Ginzinger DG; Wong DT; Schmidt BL
Clin Cancer Res; 2004 Oct; 10(19):6460-5. PubMed ID: 15475433
[TBL] [Abstract][Full Text] [Related]
11. Increased expression and activation of matrix metalloproteinase-2 (MMP-2) in O-1N: hamster oral squamous cell carcinoma with high potential lymph node metastasis.
Zhang Y; Wang C; Mizukami H; Itoh H; Kusama M; Ozawa K; Jinbu Y
J Exp Clin Cancer Res; 2006 Sep; 25(3):417-23. PubMed ID: 17167983
[TBL] [Abstract][Full Text] [Related]
12. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
[TBL] [Abstract][Full Text] [Related]
13. Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment.
Wang D; Xu X; Zhang K; Sun B; Wang L; Meng L; Liu Q; Zheng C; Yang B; Sun H
Int J Nanomedicine; 2018; 13():187-198. PubMed ID: 29343957
[TBL] [Abstract][Full Text] [Related]
14. A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
Tang XH; Albert M; Scognamiglio T; Gudas LJ
Cancer Prev Res (Phila); 2009 Dec; 2(12):1100-10. PubMed ID: 19952362
[TBL] [Abstract][Full Text] [Related]
15. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of matrix metalloproteinase-2 in oral cells after short-term stimulation and long-term usage of areca quid.
Liu SY; Lin MH; Yang SC; Huang GC; Chang L; Chang S; Yen CY; Chiang WF; Kuo YY; Chen LL; Lee CH; Liu YC
J Formos Med Assoc; 2005 Jun; 104(6):390-7. PubMed ID: 16037826
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations.
Tsai CH; Hsieh YS; Yang SF; Chou MY; Chang YC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):710-6. PubMed ID: 12789153
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
19. Functional role of matrix metalloproteinase-28 in the oral squamous cell carcinoma.
Lin MH; Liu SY; Su HJ; Liu YC
Oral Oncol; 2006 Oct; 42(9):907-13. PubMed ID: 16730219
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]